Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Research

Management perspective of COVID-19 patients from L1 till L3 level hospital: An observational study

Syed Neyaz Hasan, Ankit Srivastva, Anand Bihari, Puspendra Kumar Singh.

Background: The coronavirus (CoV) specifically known as CoVs disease (COVID)-19 spread from Wuhan city of China to the whole world and created havoc worldwide. It is an RNA virus of family beta- CoVs, and it is third CoV infection after Middle East respiratory syndrome and subacute respiratory syndrome.

Aim and Objective: The objective of this study was to assess the status of COVID-19 patients in the study area.

Materials and Methods: A hospital-based cross-sectional study was conducted in Government Medical College, Azamgarh, on the subjects either suspected or confirmed with COVID 19 tests for March 20, 2020, till the submission of this research. Oral consent was taken from all the patients. The total number of patients included in the study is 81 who were declared as COVID positive patients admitted in the isolation ward after taking throat and nasal swab followed by reverse transcription-polymerase chain reaction technique. Out of 81, 73 (90.12 %) were male and 8 (9.88 %) were female and the age varies from 8 years to 95 years with the mean age of 35.48 years. Out of total patients, 1 was referred due to critical illness, two were shifted to L1 hospital, and 27 were discharged in satisfactory conditions.

Results: The majority of patients (61.00%) were asymptomatic and the patients who were having symptoms presented sore throat and cough (32.00%), fever and cough 19%, sore throat, headache and body-ache (16.00%), cough, sore throat and chest pain (12.00%), and vomiting and pain abdomen (0.06%). Radiological investigations have suggested mild acute respiratory distress syndrome (ARDS) in almost (10.00%), and some subjects show changes in chronic obstructive pulmonary disease. There were 2 patients who showed severe changes of ARDS (

Key words: Coronavirus Disease-19; RNA virus; Reverse Transcription Polymerase Chain Reaction; Acute Respiratory Distress Syndrome; Chronic Obstructive Pulmonary Disease

Similar Articles

Promoter CAG is more efficient than hepatocyte‑targeting TBG for transgene expression via rAAV8 in liver tissues.
Kang J, Hang L, Zheng W, Luo J, Zhang X, Song Y, Liu A
Molecular medicine reports. 2022; 25(1):

Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends.
Zhang H, Elefant F
Neural regeneration research. 2022; 17(2): 325-327

Synthesis of enhanced corrosion resistant Fe-B-C-Ti amorphous ribbons and evaluation of their photodegradation efficiency under light irradiation.
Zuo M, Moztahida M, Lee DS, Yi S
Chemosphere. 2022; 287(Pt 2): 132175

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Coenzyme-catalyzed electroinitiated reversible addition fragmentation chain transfer polymerization for ultrasensitive electrochemical DNA detection.
Ma N, Liu J, Liu B, Li L, Kong J, Zhang X
Talanta. 2022; 236(): 122840

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.

ScopeMed Web Sites